Q&A NNI Symposium: HMOs: A window of opportunity or a strong weapon in strengthening immunity
Human milk oligosaccharides (HMOs) contribute to shaping the infant’s gut microbiome and immune system for immediate and long-term health benefits. HMOs are the 3rd largest solid component of human milk and over 200 HMOs have been identified so far. 2’FL and LNnT are among the most studied HMOs with clinical evidence to support immunity and the developing microbiome, but latest research on additional HMOs show promise in expanded benefits on gut, immune, brain and bone health. In this video you will be able to watch key Q&A from NNI symposium as schedule for 6th WCPGHAN on “HMOs: A window of opportunity or a strong weapon in strengthening immunity”.